Posters Overview
In 2022, with the promulgation of ICH M12, the evaluation methods for TDI in drug interactions became elusive. The original regional guidelines such as the FDA did not specify the IC50 shift method, but the M12 guidelines pointed out that the dilution method should be used for the IC50 shift. This has sparked extensive discussions in the industry. Based on the internally validated IC50 shift system, we conducted a comparative study of the dilution and non-dilution methods.
Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.